Challenges in interpreting allergen microarrays in relation to clinical symptoms: a machine learning approach. by Prosperi, MC et al.
ORIGINAL ARTICLE In v i t ro d iagnos is and biotechnology
Challenges in interpreting allergen microarrays in relation
to clinical symptoms: A machine learning approach
Mattia C. F. Prosperi1,2, Danielle Belgrave1,2, Iain Buchan1, Angela Simpson2 & Adnan Custovic2
1Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, UK; 2Centre for Respiratory Medicine and
Allergy, Institute of Inflammation and Repair, University of Manchester, Manchester, UK
To cite this article: Prosperi MCF, Belgrave D, Buchan I, Simpson A, Custovic A. Challenges in interpreting allergen microarrays in relation to clinical symptoms: A
machine learning approach. Pediatr Allergy Immunol 2014: 25: 71–79.
Keywords
component-resolved diagnostics; asthma;
wheeze; rhinitis; airway hyper-reactivity;
methacholine; IgE; children; machine
learning; feature selection; logistic
regression; random forests; Bayesian
networks
Correspondence
Mattia C. F. Prosperi, Department of
Biomedical Modelling, Centre for Health
Informatics, Institute of Population
Health, University of Manchester, 1st Floor,
Jean McFarlane Building, Room 1.314,
University Place, Oxford Road, Manchester
M13 9PL, UK
Tel.: +44 (0) 161 27 51125
E-mail: mattia.prosperi@manchester.ac.uk
Accepted for publication 30 August 2013
DOI:10.1111/pai.12139
Abstract
Background: Identifying different patterns of allergens and understanding their
predictive ability in relation to asthma and other allergic diseases is crucial for the
design of personalized diagnostic tools.
Methods: Allergen-IgE screening using ImmunoCAP ISAC assay was performed at
age 11 yrs in children participating a population-based birth cohort. Logistic regression
(LR) and nonlinear statistical learning models, including random forests (RF) and
Bayesian networks (BN), coupled with feature selection approaches, were used to
identify patterns of allergen responses associated with asthma, rhino-conjunctivitis,
wheeze, eczema and airway hyper-reactivity (AHR, positive methacholine challenge).
Sensitivity/specificity and area under the receiver operating characteristic (AUROC)
were used to assess model performance via repeated validation.
Results: Serum sample for IgE measurement was obtained from 461 of 822 (56.1%)
participants. Two hundred and thirty-eight of 461 (51.6%) children had at least one of
112 allergen components IgE > 0 ISU. The binary threshold >0.3 ISU performed less
well than using continuous IgE values, discretizing data or using other data
transformations, but not significantly (p = 0.1). With the exception of eczema
(AUROC~0.5), LR, RF and BN achieved comparable AUROC, ranging from 0.76
to 0.82. Dust mite, pollens and pet allergens were highly associated with asthma, whilst
pollens and dust mite with rhino-conjunctivitis. Egg/bovine allergens were associated
with eczema.
Conclusions: After validation, LR, RF and BN demonstrated reasonable discrimina-
tion ability for asthma, rhino-conjunctivitis, wheeze and AHR, but not for eczema.
However, further improvements in threshold ascertainment and/or value transforma-
tion for different components, and better interpretation algorithms are needed to fully
capitalize on the potential of the technology.
Detection of allergen-specific IgE antibodies (sIgE) is associ-
ated with an increased risk of wheeze/asthma, and among
asthmatic patients with more severe disease and diminished
lung function (1–4). The level of sIgE to common inhalant
allergens offers more valuable information than a simple
detection of ‘positive sIgE’ (4, 5). Different allergen sources
(both indoor and outdoor) have been independently associated
with asthma and asthma-related symptoms (6–9). However, it
remains unclear how allergen sensitizations in toto contribute
towards clinical manifestations of different atopic diseases
(e.g., asthma vs. rhino-conjunctivitis vs. eczema).
The increasing availability of allergen components (purified
from natural source or produced as recombinant proteins)
marks the shift in allergy diagnosis that may lead to a
transition towards component-resolved diagnostics (10). For
example, the multiplex chip-based assay ImmunoCAP ISAC
has been validated in terms of performance and reproducibility
(11), providing an opportunity to identify both allergen
patterns and their interactions in relation to different clinical
outcomes. Using ImmunoCAP ISAC assay, the sIgE anti-
body profiles associated with asthma, exhaled nitric oxide and
airway hyper-reactivity (AHR) have been investigated, with
multiple sensitizations to several allergen groups increasing the
risk of asthma (12).
We hypothesized that different sIgE patterns are predictive
of different diseases commonly associated with atopy; also,
different interpretation algorithms, component threshold
ascertainment and/or value transformation may modify the
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association between such patterns and clinical symptoms. To
address these hypotheses, we investigated the ability and the
interpretability of different linear and nonlinear statistical
learning models in classifying contemporaneous asthma,
wheezing, AHR, rhino-conjunctivitis and eczema. Models were
fit on sIgE levels measured by the ISAC among participants
in a population-based birth cohort at age 11 yrs. We used
machine learning methods such as decision trees (DTs) (that
divide study population into nested subgroups, based on
allergen thresholds and combinations, each with a specific
probability of manifesting clinical symptoms) and Bayesian
networks (BN) (graphs that represent causal dependencies of
variables), coupled with logistic regression (LR), to fully
exploit the large amount of information provided by the
microarray, and to associate it to clinical symptoms.
Methods
Study population and data sources
Manchester Asthma and Allergy Study is a population-based
birth cohort described in detail elsewhere (13). The study was
approved by a local ethics committee; informed consent
was obtained from all parents. All data in this manuscript
were ascertained at age 11 yrs. We administered validated
questionnaires to collect information on parentally reported
symptoms and physician-diagnosed illnesses. We measured
AHR using methacholine challenge (14).
Definition of outcomes
Current asthma
Positive answer to all three of the following questions: (i) ‘Has
your child wheezed within the past 12 months?’, (ii) ‘Has your
child received asthma medication within the past 12 months?’
and (iii) ‘Has your child ever been diagnosed with asthma?’.
Current wheeze
Positive answer to the question ‘Has your child had wheezing
or whistling in the chest in the last 12 months?’.
Current eczema
Positive answer to the question ‘Has your child had eczema in
the last 12 months?’.
Current rhino-conjunctivitis
Positive answer to the question ‘In the past 12 months, has
your child ever had a problem with sneezing, or a runny nose,
or a blocked nose when he/she did not have a cold or the flu
which was accompanied by itchy-watery eyes?’.
Airway hyper-reactivity
Provocative concentration of methacholine causing a 20%
decline in FEV1 < 16 mg/ml.
All outcomes were encoded as binary variables. Other
variables considered in the descriptive statistics were FEV1,
FVC, FEV1/FVC ratio, eNO and methacholine dose-response
ratio.
Detection of IgE antibodies
The presence of sIgE to 112 allergen components was assessed
by the ImmunoCAP ISAC (ThermoFisher Scientific, Upp-
sala, Sweden).
Transformation of sIgE values
In the analyses described below, we expressed sIgE values as
follows: (i) binarized using the threshold of 0.3 ISU; (ii)
discretized into four categories using the manufacturer’s
semiquantitative scale (<0.3 ISU, undetectable or very low;
≥0.3 and <1 ISU, low; ≥1 and <15 ISU, moderate to high;
≥15 ISU, very high); (iii) discretized using an automated
supervised discretization approach (15); (iv) continuous raw
values; (v) square-root or hyperbolic-arcsine transformation
(16); (vi) using other normalization methods such as quantile
normalization (17).
Statistical learning
For a detailed explanation of the methods, please see the
Supporting Information. Briefly, we analysed the discrimina-
tive ability of sIgE patterns in relation to clinical outcomes by
fitting a series of machine learning models. All analyses were
adjusted for gender. Statistical models were run on the subset
of patients with at least one sIgE > 0 ISU.
Logistic regression
We fitted main-effects LR using: (i) the sum of and the number
of positive sIgE values; and (ii) sIgE to all allergen components
(using different transformations). For the latter, due to the
high number of variables, LR was subject to feature selection
via LogitBoost (18).
Decision tree and random forest models
These models were fitted to investigate possible nonlinear/
interaction effects (19, 20). DTs are machine learning methods
that divide population into nested subgroups according to
values of the covariates, usually those that have the highest
discriminatory power with respect to the outcome. For
example, our study population could be divided into two using
Fel d 1 IgE below or above 0.3 ISU. Other tree-branching rules
can then be inferred on the two subpopulations, and so on
recursively until a stopping criterion is met (e.g., a minimum
number of subjects per subgroup). This progressive data
partition can be represented in the form of a tree (Fig. S1).
DTs are easy to interpret, but sometimes have poor predictive
power. RFs are an ensemble of several different DTs, fitted
with resampling/randomization, with the aim to improve
prediction performance by combining many decision pathways
(e.g., averaging across many DT predictions). DT and RF have
dedicated methods for measuring variable importance which
can capture complex interactions, without the need of explicitly
defining them.
Bayesian networks
Bayesian networks are graphs in which each node is a covariate,
and a link between two nodes represent a dependency. If no link
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is present between two nodes, they are conditionally indepen-
dent. For a comprehensive introduction to BN modelling for
biomedicine, please seeMillan et al. (21). The na€ıve Bayes (NB),
a simpler model which assumes conditional independence
among variables, was also fit as a control to BN.
Model performance
Goodness-of-fit functions for assessing prediction performance
of models included as follows: accuracy (% correct), area under
the receiver operating characteristic (AUROC), sensitivity and
specificity. The ability to generalize on unseen data was assessed
through repeated validation, executing for 50 times a random-
ized training/test procedure (80%/20%) and comparing differ-
ences between models with a paired-corrected t-test. We also
assessed power of the sample in relation to covariate size.
Results
Participants
We reviewed 822 children. Sample for IgE measurement was
obtained for 461 (56.1%); there was no difference in gender,
family history of allergic diseases, position in sibship, asthma,
sensitization (skin tests) or parental atopy between those with
and without IgE (data available on request). A total of 238 of
461 (51.6%) children tested positive (sIgE > 0.3 ISU) to at
least one allergen component. Characteristics of study partic-
ipants are shown in Table 1.
Distribution and transformation of sIgE values
The distribution of sIgE values was highly skewed; Fig. S2
shows the histograms upon several input transformations. In a
preliminary test on model performance (AUROC in relation to
asthma, using LR and RF), we found that the binary
discretization of sIgE values using the 0.3 ISU threshold was
performing less well compared with a continuous scale or a
multiple categorization. The manufacturer’s semiquantitative
scale performed better than the binary threshold, although not
significantly. The automated supervised discretization method
yielded the best results. Fig. S3 shows detailed box plots of
AUROC performance across all transformation methods.
Discriminative ability of sIgE patterns in relation to clinical
outcomes
Robustness of model performance
Average AUROC > 0.5 was achieved for asthma, wheeze,
rhino-conjunctivitis and AHR in all statistical learning models;
Table 1 Characteristics of the study population at age 11 (N = 426)
At least one IgE > 0
Median (IQR) or N
Missing
Male 154 Female 84 Total 238 N/A
N1 = 238 (51.6%)
Number of specific
positive IgE (>0.3 ISU)
7.5 (3.0–14.5) 7.0 (2.0–12.0) 7.0 (3.0–13.0) N/A
Sum of all IgE 34.0 (8.4–130.2) 38.9 (1.9–132.8) 36.4 (4.9–131.4) N/A
Asthma 33 15 48 4
Eczema 36 22 58 5
Mean eNO 14.6 (8.8–33.8) 19.9 (9.8–41.7) 17.6 (9.4–37.8) 62
FVC 2.7 (2.4–3.0) 2.5 (2.3–2.9) 2.6 (2.4–3.0) 3
% predicted FEV1 99.2 (91.0–107.4) 98.5 (92.2–103.7) 99.0 (91.6–106.0) 3
Current wheeze 48 25 73 3
AHR 62 31 93 59
Rhino-conjunctivitis 63 28 91 3
Methacholine dose-response ratio 3.20 (1.01–5.47) 3.48 (0.95–6.11) 0.98 (3.28–5.84) 57
FEV/FVC ratio 0.86 (0.81–0.90) 0.89 (0.84–0.92) 0.86 (0.82–0.91) 4
All IgE = 0 Male 101 Female 122 Total 223 N/A
N2 = 223 (48.4%)
Asthma 5 5 10 9
Eczema 15 14 29 7
Mean eNO 8.3 (6.9–10.7) 8.1 (6.5–10.4) 8.2 (6.6–10.6) 46
FVC 2.7 (2.5–3.1) 2.6 (2.3–2.9) 2.7 (2.4–3.0) 6
% Predicted FEV1 98.3 (93.0–106.1) 99.0 (91.8–106.6) 98.6 (92.5–106.5) 5
Current wheeze 8 10 18 2
Airway hyper-reactivity 23 18 41 50
Rhino-conjunctivitis 7 9 16 11
Methacholine dose-response ratio 4.69 (2.88–6.48) 5.13 (3.81–6.81) 4.99 (3.54–6.57) 53
FEV/FVC ratio 0.86 (0.82–0.90) 0.89 (0.85–0.93) 0.88 (0.83–0.92) 13
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in contrast, this was not achieved for eczema (AUROC~0.5).
However, although AUROC for eczema for all models was
poor, in the univariate analysis, sIgE to egg ovomucoid,
ovalbumin and ovotransferrin were significantly associated
with eczema (Gal d 1, p = 0.02; Gal d 2; p = 0.02; Gal d 3,
p = 0.02). We also observed a strong trend for bovine allergens
Bos d 4-5-6 (p = 0.06, p = 0.06, p = 0.04, respectively).
Overall, all models showed reasonable AUROC (0.76–0.82
for RF, 0.63–0.79 for LR, 0.56–0.77 for BN, 0.64–0.76 for NB)
and sensitivity (0.69–0.97 for RF, 0.54–0.95 for LR, 0.58–0.96
for BN, 0.62–0.92 for NB), but poor specificity (0.34–0.70 for
RF, 0.40–0.69 for LR, 0.32–0.54 for BN, 0.38–0.57 for NB),
except for the positive AHR (higher specificity, decreased
AUROC/sensitivity).
Table 2 Performance of statistical learning models by means of 50 independent validation runs, stratified by different outcomes
Outcome Method Feature set Feature/topology selection AUROC (s.d.)
Sensitivity
(s.d.)
Specificity
(s.d.)
Asthma Majority
class
N/A N/A 0.50 (0.00)* 1.00 (0.00) 0.00 (0.00)*
LR Number of positive
IgE + sum of all IgE
N/A 0.71 (0.10)* 0.96 (0.03) 0.20 (0.12)*
LR 112 IgE + gender Cross-validated LogitBoost 0.79 (0.08) 0.95 (0.03)* 0.40 (0.15)
DT 112 IgE + gender Embedded (information gain, pruning) 0.59 (0.10)* 0.96 (0.06) 0.14 (0.16)
RF 112 IgE + gender Embedded (Gini index, random subset) 0.82 (0.06) 0.97 (0.04) 0.34 (0.13)
NB 112 IgE + gender Cross-validated wrapper
(best-first search, K2)
0.76 (0.08) 0.91 (0.05)* 0.38 (0.15)
BN 112 IgE + gender Cross-validated wrapper
(best-first search, K2)
0.77 (0.07) 0.96 (0.03)* 0.32 (0.15)
Wheeze Majority
class
N/A N/A 0.50 (0.00)* 1.00 (0.00) 0.00 (0.00)*
LR Number of positive
IgE + sum of all IgE
N/A 0.67 (0.06)* 0.93 (0.04)* 0.13 (0.08)*
LR 112 IgE + gender Cross-validated LogitBoost 0.72 (0.07) 0.94 (0.05) 0.37 (0.12)
DT 112 IgE + gender Embedded (information gain, pruning) 0.61 (0.08)* 0.90 (0.09) 0.29 (0.20)
RF 112 IgE + gender Embedded (Gini index, random subset) 0.78 (0.06) 0.91 (0.05)* 0.45 (0.12)
NB 112 IgE + gender Cross-validated wrapper
(best-first search, K2)
0.69 (0.06)* 0.92 (0.06)* 0.30 (0.12)
BN 112 IgE + gender Cross-validated wrapper
(best-first search, K2)
0.65 (0.07)* 0.93 (0.10) 0.29 (0.12)
Rhino-
conjunctivitis
Majority
class
N/A N/A 0.50 (0.00)* 1.00 (0.00) 0.00 (0.00)*
LR Number of positive
IgE + sum of all IgE
N/A 0.80 (0.07) 0.84 (0.07)* 0.44 (0.11)*
LR 112 IgE + gender Cross-validated LogitBoost 0.73 (0.07)* 0.79 (0.09)* 0.53 (0.13)
DT 112 IgE + gender Embedded (information gain, pruning) 0.66 (0.06)* 0.81 (0.11)* 0.47 (0.17)
RF 112 IgE + gender Embedded (Gini index, random subset) 0.78 (0.07) 0.80 (0.08)* 0.57 (0.11)
NB 112 IgE + gender Cross-validated wrapper
(best-first search, K2)
0.75 (0.07) 0.88 (0.06)* 0.41 (0.12)*
BN 112 IgE + gender Cross-validated wrapper
(best-first search, K2)
0.73 (0.07)* 0.82 (0.08)* 0.50 (0.12)
AHR Majority
class
N/A N/A 0.50 (0.00)* 1.00 (0.00) 0.00 (0.00)*
LR Number of positive
IgE + sum of all IgE
N/A 0.57 (0.11)* 0.70 (0.19)* 0.39 (0.20)*
LR 112 IgE + gender Cross-validated LogitBoost 0.64 (0.05)* 0.55 (0.18)* 0.70 (0.23)
DT 112 IgE + gender Embedded (information gain, pruning) 0.64 (0.10)* 0.55 (0.18)* 0.70 (0.21)
RF 112 IgE + gender Embedded (Gini index, random subset) 0.76 (0.07) 0.69 (0.11)* 0.70 (0.10)
NB 112 IgE + gender Cross-validated wrapper
(best-first search, K2)
0.64 (0.10)* 0.62 (0.20)* 0.57 (0.25)
BN 112 IgE + gender Cross-validated wrapper
(best-first search, K2)
0.56 (0.06)* 0.58 (0.21)* 0.54 (0.29)
AHR, airway hyper-reactivity; AUROC, area under the receiver operating characteristic; BN, Bayesian networks; DT, Decision tree; LR, Logistic
regression; NB, na€ıve Bayes; RF, random forests.
*The hypothesis of difference in means comparing against the best model (in bold) could not be rejected at p = 0.05.
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Random forest outperformed other approaches in terms of
AUROC in all but one outcome (rhino-conjunctivitis). LR
(model ii) ranked always as the best in terms of specificity. The
number of variables selected by LogitBoost yielded a median
(IQR) of 9 (7–18) covariates permodel across all validation runs.
In most cases, the hypothesis that there was no difference in the
mean performance among the RF, LR,NB and BN could not be
rejected at the 0.05 level. Performance of DT was consistently
inferior to that ofRF (p < 0.05), and the same held forLRmodel
i (encoding the number of positive IgE + sum of all IgE), except
for rhino-conjunctivitis. Table 2 summarizes prediction perfor-
mance obtained by the repeated validation; AUROC plots are
shown in Fig. 1. For this experiment, we used the square-root
transformed sIgE, but similar results were obtained for the other
transformation methods.
Variable importance in relation to clinical outcomes and their
dependencies
Fig. 2 shows RF feature importance plots with respect to
asthma and rhino-conjunctivitis across 1000 permutation runs.
The importance is expressed as rescaled decrease in accuracy
when randomizing a variable of interest. For asthma, there was
a broader set of top-scoring allergens belonging to different
sources including dust mite, cat, dog and pollens, whilst the
top-scoring allergens for rhino-conjunctivitis were all pollens
followed by dust mite. The order of variables may change when
randomizing permutations (22); indeed, variable ranks and
associated p-values for our data set were subject to a consistent
degree of variation.
There was partial consistency between the variables selected
by the stepwise heuristic for NB/BN with the top-scoring
variables output by the RF. Similarly, runs of stepwise LR with
different starting points led to different final sets, probably due
to a number of correlated variables. Fig. 3 shows the mutually
adjusted odds ratio from LogitBoost LR, including only
variables significant (p < 0.05) in univariate analysis. Supple-
mentary results give a more thorough explanation of the
relevant variables and their association into ‘equivalency’
groups (Figs S4–S6).
Fig. 4 depicts two optimized NB and BN structures for
asthma and rhino-conjunctivitis. The networks shown here are
representative of a single run; therefore, we cannot exclude the
possibility that there are other topologies and variable sets with
comparable performance.
Discussion
Key findings
We investigated the ability of linear and nonlinear statistical
learning models fit on ISAC assay data, to identify asthma,
wheezing, AHR, rhino-conjunctivitis and eczema. In general,
all modelling techniques (excluding DRs) performed compa-
rably. With the exception of eczema, all outcomes could be
predicted with an AUROC > 0.5. Random forests (RF)
outperformed other approaches in terms of AUROC, whilst
LR ranked as the best in terms of specificity. We could not
clarify if a main-effect model or a model that hypothesizes
conditional independence among variables (LR/NB) was
performing as well as a model which accounts for interactions
or conditional dependencies (RF/BN). Based on these results,
one could argue that a simple linear score (LR) with fewer
allergen components (from 7 to 18) may be as effective as a
more complex model. However, we cannot rule out the
possibility that interactions among allergens may have a
potentially important role.
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Figure 1 Performance of statistical learning models in classifying the asthma and rhino-conjunctivitis outcomes, using the full feature set
(112 IgE + gender) by means of area under the receiver operating characteristic, across 50 independent validation (80%/20%) runs. Results are
out-of-sample predictions (i.e., on unseen data). Bars represent standard errors.
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Our data suggest that sIgE discretization and transforma-
tion policy may increase the model performance compared
with the single dichotomous threshold at 0.3 ISU. The number
of positive sIgEs and the sum of all sIgE levels were poorer
predictors of asthma, wheeze and AHR compared with the
information on all components, supporting the evaluation of
all specific components rather than an overall qualitative
assessment.
Limitations and interpretation
From a methodological point of view, one limitation of this
study lies within the procedures for feature/model selection.
A challenge within BN learning is the simultaneous estima-
tion of both node set and topology, limited here by the usage
of two nested heuristic searches. Reliability of the associa-
tions in the networks was not assessed, nor the stability of
selected feature sets. The selection of main effects and
interactions might be also dependent on the discretization
policy.
The advantage of coupling machine learning methods with
classical statistical models is that more complex mechanistic
hypotheses can be investigated and that large, sparse, hetero-
geneous data sets can be analysed. Furthermore, by comparing
performance of nonlinear and linear methods, one can ascertain
whether the unexplained variability (e.g., poor prediction of the
outcome) can be reduced by measuring other potentially
important variables, permitting formulation of new hypotheses.
Our data suggest that a careful and informed sIgE discret-
ization/transformation may increase the performance,
although the differences in AUROC of various approaches
could not be always confirmed at the formal 0.05 signifi-
cance level. The semiquantitative coding suggested by the
manufacturer performed better than using the binary threshold
at 0.3 ISU (albeit not significantly). In our data set, the
automated supervised discretization method yielded the best
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Figure 2 Feature importance plots
for the asthma outcome (upper
panel) and for the rhino-
conjunctivitis outcome (lower panel)
measured as mean decrease in
accuracy from fitting a random
forest and performing an outcome
permutation test (1000 runs). Green
intervals represent rescaled average
(standard deviation) decrease in
accuracy, whilst box plots represent
the null distribution (randomized
outcomes); p-values are highlighted
in red. Only the first 10 variables
shown.
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results, supporting the notion that a range of population-
specific (and perhaps age-specific) expected values should be
established for different populations. Given the multimodal
and skewed nature of sIgE distributions and relatively modest
sample size, further analyses in larger data sets are warranted.
We cannot exclude the possibility that different thresholds are
applicable to different components.
The heuristic algorithms for attribute selection yielded
compact sets of predictors (from hundreds to a dozen,
confirmed when applying the automated supervised discretiza-
tion approach), which simplifies the interpretation of the
results. Not surprisingly, we confirmed previous findings (12)
that mite, pollen and pet allergens are top-scoring predictors of
asthma, whilst pollens (and mite) are for rhino-conjunctivitis.
However, execution of the feature selection algorithms multiple
times led to variations in the sets and scores. This may be in
part due to highly correlated variables, but also other latent
causes. Such variability does not permit identification of one
unique model, and therefore, a unique pathway. Our results
suggest that pre-clustering of allergens into relevant families
may help stabilize the feature selection phases and may
potentially be more useful than standard classifications by
source (e.g., pollen or mite).
The prediction models for eczema had poor performance,
suggesting either that disruption in skin barrier function may
be more important in the pathogenesis of eczema than IgE-
mediated mechanisms or that other allergens not available on
the chip may be predictive of eczema (e.g., Staphylococcus
aureus enterotoxins) (23).
Conclusions
Component-resolved diagnostic tests may offer a more
accurate assessment of allergic diseases. However, further
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Figure 3 Multivariable logistic regression for asthma and rhino-conjunctivitis outcomes (upper and lower panel, respectively), showing mutually
adjusted odds ratios and associated p-values from the LogitBoost algorithm (run on the whole data set). Only variables significant in the
univariate analysis were included (p < 0.05).
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improvements in threshold ascertainment and/or value trans-
formations for different allergen components, well-thought-out
interpretation algorithms and selection of components are
needed to fully capitalize on the potential of the technology.
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Supporting Information
Additional Supporting Information may be found in the online
version of this article:
Figure S1. Example of a decision tree, classifying an
outcome of interest (1/2) based on the values of variables x,
y and z.
Figure S2. Distribution of IgE values from the ISAC chip
(ISU scale) by selecting all (left panels) and strictly positive (>0,
right panel) values.
Figure S3. Performance of RF and LR models by varying
the input IgE transformation function, specifically (from left to
right): binary 0.3 ISU threshold (blue colour), column-wise
quartile discretisation, matrix-wise quartile discretisation,
square-root transform, raw values, supervised discretisation,
matrix-wise standardisation, quantile normalisation, and man-
ufacturer’s semi-quantitative scale.
Figure S4. Correlation plots for allergen IgEs. Spearman
rank-correlation was used, and the correlation matrix has been
sorted to group highly-correlated allergen groups.
Figure S5. Hierarchical clustering of allergen IgEs. Man-
hattan (L1 norm) distance was used, aggregating instances
progressively with the complete linkage method.
Figure S6. Thresholded adjacency graph of allergen IgE,
based on Spearman’s rank-correlation.
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